[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Mbx Biosciences Inc (MBX)

Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mbx Biosciences Inc 11711 N. Meridian Street Suite 300 Carmel IN 46032 USA

https://mbxbio.com Employees: 63 P: 317-659-0200

Sector:

Medical

Description:

MBX Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company's pipeline includes its lead product candidate MBX 2109, MBX 1416 and MBX 4291. MBX Biosciences Inc. is based in CARMEL, Ind.

Key Statistics

Overview:

Market Capitalization, $K 3,034,080
Enterprise Value, $K 2,958,790
Shares Outstanding, K 48,160
Float, K 33,187
% Float 68.91%
Short Interest, K 5,189
Short Float 10.77%
Days to Cover 8.52
Short Volume Ratio 0.59
% of Insider Shareholders 31.09%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -86,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -37,100 K
EBIT, $ -117,920 K
EBITDA, $ -117,670 K

Growth:

1-Year Return 341.49%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 08/06/26
Next Earnings Date 11/05/26
Earnings Per Share ttm -2.41
EPS Growth vs. Prev Qtr -52.94%
EPS Growth vs. Prev Year -34.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 12/31/69
Dividend Payout Ratio 0.00%

MBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.02%
Return-on-Assets % -24.94%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 7.72
Book Value/Share 8.60
Interest Coverage -3.60
60-Month Beta 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.